View All Documents & Correspondence
"Inhibitors Of Phosphodiesterase Type Iv"
Abstract: The present invention relates to isoxazoline derivatives, which can be used as selective inhibitors of phosphodiesterase (PDE) type IV. Compounds disclosed herein can be useful in the treatment of AIDS, asthma, arthritis, bronchitis, chronic obstructive pulmonary disease (COPD), psoriasis, allergic rhinitis, shock, atopic dermatitis, Crohn"s disease, adult respiratory distress syndrome (ARDS), eosinophilic granuloma, allergic conjunctivitis, osteoarthritis, ulcerative colitis and other inflammatory diseases especially in humans. Processes for the preparation of disclosed compounds are provided, as well as pharmaceutical compositions containing the disclosed compounds, and their use as phosphodiesterase (PDE) type IV inhibitors.
Notices, Deadlines & Correspondence
Patent Information
Applicants
RANBAXY LABORATORIES LIMITED
Inventors
1. VENKATA P.PALLE
2. SARALA BALACHANDRAN
3. LALIT KUMAR BAREGAMA
4. SASWATI CHAKLADAR
5. SARIKA RAMNAMI
6. NAGARAJAN MUTHUKAMAL
7. ABHIJIT RAY
8. SUNANDA G. DASTIDAR
Specification
Documents
Application Documents
| # | Name | Date |
|---|---|---|
| 1 | 2378-del-2005-abstract.pdf | 2011-08-21 |
| 1 | 2378-del-2005-form-2.pdf | 2011-08-21 |
| 2 | 2378-del-2005-correspondence-others.pdf | 2011-08-21 |
| 2 | 2378-del-2005-form-1.pdf | 2011-08-21 |
| 3 | 2378-del-2005-correspondence-po.pdf | 2011-08-21 |
| 3 | 2378-del-2005-description (provisional).pdf | 2011-08-21 |
| 4 | 2378-del-2005-correspondence-po.pdf | 2011-08-21 |
| 4 | 2378-del-2005-description (provisional).pdf | 2011-08-21 |
| 5 | 2378-del-2005-correspondence-others.pdf | 2011-08-21 |
| 5 | 2378-del-2005-form-1.pdf | 2011-08-21 |
| 6 | 2378-del-2005-abstract.pdf | 2011-08-21 |
| 6 | 2378-del-2005-form-2.pdf | 2011-08-21 |